Sage Therapeutics, Inc (SAGE) Covered Calls

Sage Therapeutics, Inc covered calls Sage Therapeutics Inc is a biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system disorders, where there are inadequate or no approved existing therapies.

You can sell covered calls on Sage Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SAGE (prices last updated Mon 4:16 PM ET):

Sage Therapeutics, Inc (SAGE) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
107.55 +4.87 105.50 109.00 384K - 0.0B
Covered Calls For Sage Therapeutics, Inc (SAGE)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 108 4.20 104.80 3.1% 94.3%
Jan 18 110 10.30 98.70 10.4% 94.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

SAGE Therapeutics, Inc. is a biopharmaceutical company committed to developing and commercializing novel medicines to treat life threatening, rare central nervous system disorders. Its program SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. The company's robust chemistry platform has generated multiple new compounds that target the GABAA and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders. SAGE Therapeutics was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.